A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

By Neil D. Woodward, S. Purdon, H. Meltzer, David H. Zald. International Journal of Neuropsychopharmacology, 2005

604 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007, background): “rocognitive benefit to patients with schizophrenia than first-generation, “typical” antipsychotics, many of these studies have had substantial weaknesses, such as small sample sizes, short duration of treatment, no comparator or a comparator of relatively high doses of firstgeneration antipsychotic ”